about
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats.Neuroprotective Mechanisms of Taurine against Ischemic Stroke.Practical strategies for modulating foam cell formation and behavior.The beneficial effects of taurine in preventing metabolic syndrome.Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health.
P2860
Q28393421-40B8C3EB-C553-4858-808A-5CE599051FF9Q36153690-E393C242-8485-4F75-A83A-791BD7309B20Q37064717-7229CD44-5E82-4EF9-AB79-164971408B0AQ38222884-4721261D-102B-48EC-9E82-FB09059ABF59Q38261037-49BDE510-75B3-4C77-9427-8B12C5B1169AQ38751170-FDECFF61-7782-4708-9BF4-B465FE610179Q42338456-4057B574-A946-40F7-87F0-23B92C0ECD30
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Taurine and atherosclerosis.
@en
type
label
Taurine and atherosclerosis.
@en
prefLabel
Taurine and atherosclerosis.
@en
P2860
P1433
P1476
Taurine and atherosclerosis.
@en
P2093
Shigeru Murakami
P2860
P2888
P356
10.1007/S00726-012-1432-6
P577
2012-12-08T00:00:00Z